Core 3: Biostatistics, Bioinformatics & Data Management (BBD) SUMMARY/ABSTRACT The overall goal of Core 3, the Biostatistics, Bioinformatics and Data Management (BBD) Core, is to provide comprehensive support in the areas of biostatistics, bioinformatics, and data management for all research Projects, Developmental Research and Career Enhancement programs, and Cores in the UCLA SPORE in Brain Cancer. The BBD Core is comprised of multiple faculty members from the departments of Biostatistics, Biomathematics, Molecular, Cell, & Developmental Biology (MCDB), and the UCLA Institute of Quantitative & Computational Biosciences (QCB), as well as staff statisticians, database managers, bioinformaticians, database and applications development programmers, and web designers. Faculty members include nationally respected biostatisticians and bioinformaticians with broad expertise in general biostatistics, design and analysis of clinical trials, analysis and interpretation of high-dimensional tissue arrays and gene expression data, and next generation sequencing (NGS) data analysis and management, which are needed by the SPORE research projects. Collectively and individually, the members have participated in hundreds of studies involving diverse aspects of cancer research, especially translational research. They have experience working in large centers and have served on multiple NIH study sections and review committees. The Core?s biostatistics/bioinformatics faculty and staff are actively involved in UCLA Jonsson Comprehensive Cancer Center (JCCC) current projects and have an established a history of productive collaborations with many researchers in this proposed SPORE. The BBD Core works closely with the UCLA SPORE in Brain Cancer investigators to provide input on study design, statistical analysis plans, bioinformatics, data management issues.

Public Health Relevance

Core 3: Biostatistics, Bioinformatics & Data Management (BBD) NARRATIVE The BBD Core aims to foster an outstanding environment in which to conduct translational research in brain cancer by providing the UCLA SPORE in Brain Cancer investigators with leading edge biostatistics, bioinformatics and data management support for all research Projects, the Developmental Research and Career Enhancement programs, and other Cores of the SPORE. Having the breadth of expertise readily available will facilitate the rigor and efficiency for SPORE projects. It is an indispensible shared resource central to the success of the SPORE studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA211015-03
Application #
9752973
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
3
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Orozco, Luz D; Farrell, Colin; Hale, Christopher et al. (2018) Epigenome-wide association in adipose tissue from the METSIM cohort. Hum Mol Genet 27:2586
Cheng, Lucy; Marinelli, Laura J; Grosset, Noël et al. (2018) Complete genomic sequences of Propionibacterium freudenreichii phages from Swiss cheese reveal greater diversity than Cutibacterium (formerly Propionibacterium) acnes phages. BMC Microbiol 18:19
Pope, Whitney B; Brandal, Garth (2018) Conventional and advanced magnetic resonance imaging in patients with high-grade glioma. Q J Nucl Med Mol Imaging 62:239-253
Woo, Jin Seok; Srikanth, Sonal; Kim, Kyun-Do et al. (2018) CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 Responses. J Immunol 201:1174-1185
Vespa, Paul M; Shrestha, Vikesh; Abend, Nicholas et al. (2018) The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker: Study design and protocol. Neurobiol Dis :
Cloughesy, Timothy F; Drappatz, Jan; de Groot, John et al. (2018) Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy. Neuro Oncol 20:259-267
Alexander, Brian M; Cloughesy, Timothy F (2018) Platform trials arrive on time for glioblastoma. Neuro Oncol 20:723-725
Grasso, Catherine S; Giannakis, Marios; Wells, Daniel K et al. (2018) Genetic Mechanisms of Immune Evasion in Colorectal Cancer. Cancer Discov 8:730-749
Ratai, Eva-Maria; Zhang, Zheng; Fink, James et al. (2018) ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy. PLoS One 13:e0198548
Wing, Sam E; Bandoli, Gretchen; Telesca, Donatello et al. (2018) Chronic exposure to inhaled, traffic-related nitrogen dioxide and a blunted cortisol response in adolescents. Environ Res 163:201-207

Showing the most recent 10 out of 91 publications